Lymphoma is a type of cancer that affects the lymphatic system, which plays a crucial role in immunity. With over 80 different types of lymphoma, it can be overwhelming for medical professionals to differentiate and understand each one. Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Mantle Cell Lymphoma – these are just some examples of the many variants of this disease. In this blog post, we will break down the different types of lymphoma and provide you with essential information on how fast it grows and its possible causes. As medical professionals, understanding these details is vital in diagnosing and treating patients efficiently. Let's dive deeper into what you need to know about lymphomas!
Lymphoma is a type of cancer that starts in the lymphatic system, which consists of lymph nodes, vessels, and organs. There are two primary types of lymphoma: Hodgkin Lymphoma (HL) and Non-Hodgkin Lymphoma (NHL).
Hodgkin Lymphoma is characterized by the presence of Reed-Sternberg cells in affected tissues. This type of lymphoma accounts for only 10% to 15% of all cases but has a higher cure rate than other types.
Non-Hodgkin Lymphomas represent around 85% to 90% of all cases. It originates from B cells or T cells and can have several subtypes depending on its molecular characteristics.
Mantle Cell Lymphoma is an aggressive subtype that arises from B-cells located at the mantle zone surrounding germinal centers in secondary follicles; it is challenging to treat due to its resistance to chemotherapy.
One of the most important factors to consider when dealing with lymphoma is how fast it grows. Lymphomas can grow at different rates, depending on various factors such as the type and stage of the disease.
Hodgkin lymphoma tends to grow more slowly than non-Hodgkin lymphomas. In fact, some patients may not experience any symptoms for several years after being diagnosed with Hodgkin's.
On the other hand, aggressive non-Hodgkin lymphomas can grow very rapidly and require immediate treatment. These types of lymphomas often cause significant symptoms such as fever, night sweats and weight loss.
The exact cause of lymphoma is still unknown, but researchers have identified several risk factors that may increase the likelihood of developing this type of cancer. One potential cause is a weakened immune system due to certain infections, such as HIV or Epstein-Barr virus. Exposure to radiation and certain chemicals can also increase the risk.
Additionally, genetic mutations may play a role in the development of lymphoma. Some people with a family history of lymphoma are at higher risk for developing the disease themselves.
Age also plays an important factor in developing lymphoma. Most cases occur in individuals over 60 years old, although it can affect people of any age.
Hodgkin Lymphoma is one of the most treatable forms of cancer with high survival rates, while Non-Hodgkin Lymphomas are more diverse in nature and can be challenging to diagnose due to their similarities with other diseases. It's essential to conduct an accurate diagnosis through biopsy or imaging tests to determine the appropriate treatment method.
1.
According to a study, breast cancer in Syrian refugees tends to be diagnosed at an earlier stage and with more advanced tumors.
2.
A prostate cancer risk prediction algorithm could help target men at highest risk
3.
The way that miR-377 inhibits cells that cause prostate cancer.
4.
In Advanced Myxoid Liposarcoma, Is Trabectedin Winning?
5.
Study indicates that exercise can help colon cancer survivors live as long as matched individuals
1.
A Review on Genetic Predispositions and Clinical Advancements of Multiple Myeloma Cancer
2.
AI-Powered Strategies for Precision and Improved Outcomes in Esophageal Cancer, a Global Health Crisis
3.
Claudin-18.2 in Gastric Cancer: Tumor-Stroma Crosstalk and Disease Progression
4.
Cracking the Code of Subdural Hematomas: Modern Strategies for Optimal Care
5.
The Benefits and Risks of Transurethral Resection of Bladder Tumor
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Efficient Management of First line ALK-rearranged NSCLC
2.
Newer Immunotherapies for Myeloma- A Comprehensive Overview- Part II
3.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
4.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV
5.
Oropharyngeal Cancer in Relation to HPV Status
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation